Protein-protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthase

Abstract:
No abstract specified

SEEK ID: https://publications.h-its.org/publications/591

DOI: 10.1073/pnas.1104829108

Research Groups: Molecular and Cellular Modeling

Publication type: Journal

Journal: Proceedings of the National Academy of Sciences

Citation: Proceedings of the National Academy of Sciences 108(34):E542-E549

Date Published: 23rd Aug 2011

Registered Mode: by DOI

Authors: D. Cardinale, G. Guaitoli, D. Tondi, R. Luciani, S. Henrich, O. M. H. Salo-Ahen, S. Ferrari, G. Marverti, D. Guerrieri, A. Ligabue, C. Frassineti, C. Pozzi, S. Mangani, D. Fessas, R. Guerrini, G. Ponterini, R. C. Wade, M. P. Costi

Citation
Cardinale, D., Guaitoli, G., Tondi, D., Luciani, R., Henrich, S., Salo-Ahen, O. M. H., Ferrari, S., Marverti, G., Guerrieri, D., Ligabue, A., Frassineti, C., Pozzi, C., Mangani, S., Fessas, D., Guerrini, R., Ponterini, G., Wade, R. C., & Costi, M. P. (2011). Protein–protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthase. In Proceedings of the National Academy of Sciences (Vol. 108, Issue 34). Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1104829108
Activity

Views: 5568

Created: 6th Dec 2019 at 15:36

Last updated: 5th Mar 2024 at 21:24

help Tags

This item has not yet been tagged.

help Attributions

None

Powered by
(v.1.14.2)
Copyright © 2008 - 2023 The University of Manchester and HITS gGmbH